P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function

RJ Roman - Physiological reviews, 2002 - journals.physiology.org
Recent studies have indicated that arachidonic acid is primarily metabolized by cytochrome
P-450 (CYP) enzymes in the brain, lung, kidney, and peripheral vasculature to 20 …

Regulation of cytochrome p450 by inflammatory mediators: why and how?

ET Morgan - Drug metabolism and disposition, 2001 - ASPET
Expression and activities of cytochrome P450 enzymes are down-regulated in the liver
during the host response to inflammation or infection, leading to alterations in drug …

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries

I Fleming, UR Michaelis, D Bredenkötter… - Circulation …, 2001 - Am Heart Assoc
In the porcine coronary artery, a cytochrome P450 (CYP) isozyme homologous to CYP
2C8/9 has been identified as an endothelium-derived hyperpolarizing factor (EDHF) …

[HTML][HTML] Dominant role of smooth muscle L-type calcium channel Cav1. 2 for blood pressure regulation

S Moosmang, V Schulla, A Welling, R Feil, S Feil… - The EMBO …, 2003 - embopress.org
Blood pressure is regulated by a number of key molecules involving G-protein-coupled
receptors, ion channels and monomeric small G-proteins. The relative contribution of these …

Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium

J Vriens, G Owsianik, B Fisslthaler, M Suzuki… - Circulation …, 2005 - Am Heart Assoc
TRPV4 is a broadly expressed Ca2+-permeable cation channel in the vanilloid subfamily of
transient receptor potential channels. TRPV4 gates in response to a large variety of stimuli …

Cytochrome p450 and vascular homeostasis

I Fleming - Circulation research, 2001 - Am Heart Assoc
Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize
arachidonic acid to substances which affect arterial tone, it has become increasingly clear …

Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics

AE Rettie, JP Jones - Annu. Rev. Pharmacol. Toxicol., 2005 - annualreviews.org
▪ Abstract CYP2C9 is a major cytochrome P450 enzyme that is involved in the metabolic
clearance of a wide variety of therapeutic agents, including nonsteroidal antiinflammatories …

Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities

ML Brocq, SJ Leslie, P Milliken… - Antioxidants & redox …, 2008 - liebertpub.com
Endothelial dysfunction has been implicated as a key factor in the development of a wide
range of cardiovascular diseases, but its definition and mechanisms vary greatly between …

The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease

I Fleming - Pharmacological reviews, 2014 - ASPET
Over the last 20 years, it has become clear that cytochrome P450 (P450) enzymes generate
a spectrum of bioactive lipid mediators from endogenous substrates. However, studies …

Endothelium‐dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

TM Griffith - British journal of pharmacology, 2004 - Wiley Online Library
An endothelium‐derived hyperpolarizing factor (EDHF) that is distinct from nitric oxide (NO)
and prostanoids has been widely hypothesized to hyperpolarize and relax vascular smooth …